WWMSC
ANIK icon

Wagner Wealth Management (South Carolina)’s Anika Therapeutics ANIK Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$0 Hold
10
– – ﹤0.01% 696
2018
Q2 		$0 Hold
10
– – ﹤0.01% 671
2018
Q1 		$0 Buy
+10
New +$565 ﹤0.01% 628
2017
Q4 		– Hold
0
– – – 712

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s ANIK Position: Q3 2018 in Review

Wagner Wealth Management (South Carolina) held its Anika Therapeutics (ANIK) position steady in Q3 2018 at 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Wagner Wealth Management (South Carolina) first reported a position in ANIK in Q1 2018 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold ANIK as of Q3 2018.

  • Wagner Wealth Management (South Carolina) held 10 shares of Anika Therapeutics worth $0 as of Q3 2018.
  • Wagner Wealth Management (South Carolina) left its Anika Therapeutics share count unchanged in Q3 2018.
  • Anika Therapeutics made up ﹤0.01% of Wagner Wealth Management (South Carolina)'s portfolio in Q3 2018, its #696 holding.
  • Wagner Wealth Management (South Carolina) first reported a position in Anika Therapeutics in Q1 2018 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2018, filed 5 Nov 2018.